305 related articles for article (PubMed ID: 24505197)
1. Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
Lee K; Jung H; Sohn J
Korean J Ophthalmol; 2014 Feb; 28(1):19-25. PubMed ID: 24505197
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.
Byun YJ; Roh MI; Lee SC; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):963-71. PubMed ID: 20182882
[TBL] [Abstract][Full Text] [Related]
5. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
Kim JY; Park SP
Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
7. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
[TBL] [Abstract][Full Text] [Related]
8. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.
Hayashi A; Yunoki T; Miyakoshi A; Mitarai K; Fujino T; Yanagisawa S
Jpn J Ophthalmol; 2011 Nov; 55(6):625-31. PubMed ID: 21909658
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
[TBL] [Abstract][Full Text] [Related]
12. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU; Ip MS; VanVeldhuisen PC; Oden NL; Blodi BA; Fisher M; Chan CK; Gonzalez VH; Singerman LJ; Tolentino M;
Arch Ophthalmol; 2009 Sep; 127(9):1115-28. PubMed ID: 19752420
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
Alshareef RA; Garg SJ; Hsu J; Vander J; Park C; Spirn MJ
J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
Lu Y; Su L; Xu X
J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
[TBL] [Abstract][Full Text] [Related]
16. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.
Yang CS; Liu JH; Chung YC; Chou YB; Hung KH
J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.
Hanada N; Iijima H; Sakurada Y; Imasawa M
Jpn J Ophthalmol; 2012 Mar; 56(2):165-74. PubMed ID: 22183139
[TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
